Imaging hypoxia after oxygenation-modification: Comparing [ 18F]FMISO autoradiography with pimonidazole immunohistochemistry in human xenograft tumors

Radiotherapy and Oncology

Volumn 80, Issue 2, 2006, Pages 157-164

  Troost, Esther G C ^a   Laverman, Peter ^b   Kaanders, Johannes H A M ^a   Philippens, Mariëlle ^a   Lok, Jasper ^a   Oyen, Wim J G ^b   van der Kogel, Albert J ^a   Boerman, Otto C ^b   Bussink, Johan ^a  

^a Department of Radiation Oncology ^*  (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

18F Fluoromisonidazole; Carbogen; Digital autoradiography; Hypoxia; Pimonidazole

Indexed keywords

1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL F 18; PIMONIDAZOLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CANCER CELL CULTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; GLIOBLASTOMA; HEAD AND NECK CARCINOMA; HYPOXIA; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; XENOGRAFT;

ANIMALS; AUTORADIOGRAPHY; CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; FLUORINE RADIOISOTOPES; GLIOBLASTOMA; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED BALB C; MICE, NUDE; MISONIDAZOLE; NEOPLASMS; NITROIMIDAZOLES; OXYGEN; RADIATION-SENSITIZING AGENTS;

EID: 33748185692     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2006.07.023     Document Type: Article

References (32)

1. Bentzen L., Keiding S., Horsman M.R., et al. Feasibility of detecting hypoxia in experimental mouse tumours with 18F-fluorinated tracers and positron emission tomography - a study evaluating [18F]Fluoro-2-deoxy-d-glucose. Acta Oncol 39 (2000) 629-637
2. Bentzen L., Keiding S., Nordsmark M., et al. Tumour oxygenation assessed by 18F-fluoromisonidazole PET and polarographic needle electrodes in human soft tissue tumours. Radiother Oncol 67 (2003) 339-344
3. Bussink J., Kaanders J.H., Rijken P.F., et al. Vascular architecture and microenvironmental parameters in human squamous cell carcinoma xenografts: effects of carbogen and nicotinamide. Radiother Oncol 50 (1999) 173-184
4. Bussink J., Kaanders J.H., and van der Kogel A.J. Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers. Radiother Oncol 67 (2003) 3-15
5. Dewhirst M.W., Ong E.T., Rosner G.L., et al. Arteriolar oxygenation in tumour and subcutaneous arterioles: effects of inspired air oxygen content. Br J Cancer Suppl 27 (1996) S241-S246
6. Dubois L., Landuyt W., Haustermans K., et al. Evaluation of hypoxia in an experimental rat tumour model by [(18)F]Fluoromisonidazole PET and immunohistochemistry. Br J Cancer 91 (2004) 1947-1954
7. Eschmann S.M., Paulsen F., Reimold M., et al. Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy. J Nucl Med 46 (2005) 253-260
8. Evans S.M., Hahn S., Pook D.R., et al. Detection of hypoxia in human squamous cell carcinoma by EF5 binding. Cancer Res 60 (2000) 2018-2024
9. Evans S.M., Judy K.D., Dunphy I., et al. Comparative measurements of hypoxia in human brain tumors using needle electrodes and EF5 binding. Cancer Res 64 (2004) 1886-1892
10. Gronroos T., Bentzen L., Marjamaki P., et al. Comparison of the biodistribution of two hypoxia markers [18F]FETNIM and [18F]FMISO in an experimental mammary carcinoma. Eur J Nucl Med Mol Imaging 31 (2004) 513-520
11. Hedley D., Pintilie M., Woo J., et al. Carbonic anhydrase IX expression, hypoxia, and prognosis in patients with uterine cervical carcinomas. Clin Cancer Res 9 (2003) 5666-5674
12. Hockel M., and Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 93 (2001) 266-276
13. Honess D.J., and Bleehen N.M. Perfusion changes in the RIF-1 tumour and normal tissues after carbogen and nicotinamide, individually and combined. Br J Cancer 71 (1995) 1175-1180
14. Horsman M.R., Nordsmark M., Khalil A.A., et al. Reducing acute and chronic hypoxia in tumours by combining nicotinamide with carbogen breathing. Acta Oncol 33 (1994) 371-376
15. Jonathan R.A., Wijffels, KIEM, Peeters W., et al. The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON. Radiother Oncol 79 (2006) 288-297
16. Kaanders J.H., Wijffels K.I., Marres H.A., et al. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer. Cancer Res 62 (2002) 7066-7074
17. Koh W.J., Rasey J.S., Evans M.L., et al. Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole. Int J Radiat Oncol Biol Phys 22 (1992) 199-212
18. Lartigau E., Vitu L., Haie-Meder C., et al. Feasibility of measuring oxygen tension in uterine cervix carcinoma. Eur J Cancer 28A (1992) 1354-1357
19. Lim J.L., and Berridge M.S. An efficient radiosynthesis of [18F]fluoromisonidazole. Appl Radiat Isot 44 (1993) 1085-1091
20. Nordsmark M., Overgaard M., and Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol 41 (1996) 31-39
21. Nordsmark M., and Overgaard J. A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy. Radiother Oncol 57 (2000) 39-43
22. Nordsmark M., Loncaster J., Aquino-Parsons C., et al. Measurements of hypoxia using pimonidazole and polarographic oxygen-sensitive electrodes in human cervix carcinomas. Radiother Oncol 67 (2003) 35-44
23. Nordsmark M., Bentzen S.M., Rudat V., et al. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother Oncol 77 (2005) 18-24
24. Raleigh J.A., Calkins-Adams D.P., Rinker L.H., et al. Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker. Cancer Res 58 (1998) 3765-3768
25. Rasey J.S., Koh W.J., Evans M.L., et al. Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients. Int J Radiat Oncol Biol Phys 36 (1996) 417-428
26. Rijken P.F., Bernsen H.J., Peters J.P., et al. Spatial relationship between hypoxia and the (perfused) vascular network in a human glioma xenograft: a quantitative multi-parameter analysis. Int J Radiat Oncol Biol Phys 48 (2000) 571-582
27. Rijpkema M., Kaanders J.H., Joosten F.B., et al. Effects of breathing a hyperoxic hypercapnic gas mixture on blood oxygenation and vascularity of head-and-neck tumors as measured by magnetic resonance imaging. Int J Radiat Oncol Biol Phys 53 (2002) 1185-1191
28. Sorensen B.S., Hao J., Overgaard J., et al. Influence of oxygen concentration and pH on expression of hypoxia induced genes. Radiother Oncol 76 (2005) 187-193
29. Sorger D., Patt M., Kumar P., et al. [18F]Fluoroazomycinarabinofuranoside (18FAZA) and [18F]Fluoromisonidazole (18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors. Nucl Med Biol 30 (2003) 317-326
30. Troost E.G., Bussink J., Kaanders J.H., et al. Comparison of different methods of CAIX quantification in relation to hypoxia in three human head and neck tumor lines. Radiother Oncol 76 (2005) 194-199
31. van der Sanden B.P., Heerschap A., Hoofd L., et al. Effect of carbogen breathing on the physiological profile of human glioma xenografts. Magn Reson Med 42 (1999) 490-499
32. Yang D.J., Wallace S., Cherif A., et al. Development of F-18-labeled fluoroerythronitroimidazole as a PET agent for imaging tumor hypoxia. Radiology 194 (1995) 795-800